TFF Pharmaceuticals Inc (TFFP)
0.3761
-1.22
(-76.49%)
USD |
NASDAQ |
Nov 15, 16:00
0.3651
-0.01
(-2.92%)
After-Hours: 20:00
TFF Pharmaceuticals Shareholders Equity (Quarterly): 5.877M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 5.877M |
March 31, 2024 | 5.304M |
December 31, 2023 | 9.567M |
September 30, 2023 | 13.69M |
June 30, 2023 | 12.28M |
March 31, 2023 | 16.54M |
December 31, 2022 | 22.88M |
September 30, 2022 | 18.02M |
June 30, 2022 | 23.94M |
March 31, 2022 | 31.59M |
December 31, 2021 | 38.74M |
Date | Value |
---|---|
September 30, 2021 | 47.74M |
June 30, 2021 | 55.62M |
March 31, 2021 | 59.54M |
December 31, 2020 | 37.34M |
September 30, 2020 | 41.58M |
June 30, 2020 | 21.84M |
March 31, 2020 | 25.39M |
December 31, 2019 | 27.64M |
September 30, 2019 | 8.844M |
June 30, 2019 | 12.18M |
December 31, 2018 | 9.244M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
5.304M
Minimum
Mar 2024
59.54M
Maximum
Mar 2021
27.11M
Average
23.94M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
Eyenovia Inc | -2.370M |
NovaBay Pharmaceuticals Inc | 1.072M |
Palatin Technologies Inc | -0.1115M |
iBio Inc | 21.32M |
Theriva Biologics Inc | 27.65M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 9.496M |
Total Liabilities (Quarterly) | 3.618M |
Current Ratio | 1.625 |